The LifeStent™ Vascular Stent is FDA-approved stent for the SFA and popliteal artery.
Long term sustained effectiveness up to three years, and treatment superiority over balloon angioplasty.
true
Support
West Africa
+233 302 769 692
West Africa Secant Tower West Wings, 4th Floor, Secant Tower, Plot #398, Papa Monrovia Street, 7th Lane Osu Kuku Hills, Accra Ghana
Thank you for contacting our sales team!
A sales representive will get in touch with you shortly.
East Africa
+254 20 2738339/40
Africa Re Center, 2nd FL, Hospital Rd, Upper Hill, P.O. Box 76613 – 00508, Nairobi, Kenya
+254 758 726613
East & West Africa
ODE.africa@bd.com
serviceclaims.africa@bd.com
South Africa
+27 10 201 7400
20 Woodlands Drive, The Woodllands Office Park Build 6 (G), Woodmead, Johannesburg, Gauteng, 2191
orderssa@bd.com
- Overview
- Products & Accessories
- EIFU & Resources
- FAQ
true
FDA-approved for the SFA and popliteal artery
1. As of December 2020
2. Laird et al. Nitinol Stent Implantation vs. Balloon Angioplasty for Lesions in the Superficial Femoral and Proximal Popliteal Arteries of Patients With Claudication: Three-Year Follow-up From the RESILIENT Randomized Trial. J Endovasc Ther. 2012;19:1-9. The LifeStent® 5 mm diameter was not included in this trial.
3. RESILIENT I Trial, RESILIENT II Trial, E-TAGIUSS Trial, Retrospective Analysis of LifeStent® Vascular Stent Systems in the Treatment of Long-Segment Lesions, LifeStent® Vascular Stent Delivery System Study (LifeStent® 200 mm Trial),REALITY I Trial,REALITY II Trial, ETAP Trial, CONTINUUM Trial, and RELIABLE Trial. Additional trials ongoing.
Please consult Instructions for Use for product indications for use, contraindications, warnings, precautions, complications, adverse events and detailed safety information.
true
true
Literature
BD's collection of literature on industry and on our offerings gives you information you can use to continue striving for excellence.
Learn more
Case Studies
BD promotes clinical excellence by providing various resources on best practices, clinical innovations and industry trends in healthcare.
Learn more
true
false
1. As of December 2020
2. Laird et al. Nitinol Stent Implantation vs. Balloon Angioplasty for Lesions in the Superficial Femoral and Proximal Popliteal Arteries of Patients With Claudication: Three-Year Follow-up From the RESILIENT Randomized Trial. J Endovasc Ther. 2012;19:1-9. The LifeStent® 5 mm diameter was not included in this trial.
3. RESILIENT I Trial, RESILIENT II Trial, E-TAGIUSS Trial, Retrospective Analysis of LifeStent® Vascular Stent Systems in the Treatment of Long-Segment Lesions, LifeStent® Vascular Stent Delivery System Study (LifeStent® 200 mm Trial),REALITY I Trial,REALITY II Trial, ETAP Trial, CONTINUUM Trial, and RELIABLE Trial. Additional trials ongoing.
Please consult Instructions for Use for product indications for use, contraindications, warnings, precautions, complications, adverse events and detailed safety information.
true
BD-162742
true